ArticleActa pharmacologica Sinica2022

CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.

Ze-An Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.